Navigation Links
R-Squared and MDMA Announce Partnership
Date:6/16/2008

Relationship Provides the Medical Device Industry with Best-of-Breed

Compliance Solutions

PRINCETON JUNCTION, N.J., June 16 /PRNewswire/ -- R-Squared, an industry leader in compliance consulting and solutions, announced a multi-year partnership with the Medical Device Manufacturers Association ("MDMA"), a national trade association, based in Washington, D.C., representing more than 175 members, including manufacturers of medical devices and diagnostic products. Though the partnership, which was announced at the MDMA Annual Meeting, R-Squared will serve as MDMA's preferred provider of Evidence-Based Compliance management systems, including programs that demonstrate best practices around financial relationships with, and tracking spending to, physicians and other referral sources.

"We could not be more excited about our partnership with MDMA," said Michael Bell, Esq., Founder and Managing Member of R-Squared. "Our affordable next generation solutions are designed specifically to improve the performance and data analytics capabilities of device manufacturers, while at the same time preventing problems from occurring and evidencing compliance best practices." At the Annual Meeting, Michael also participated on the panel of experts to discuss "Key Fraud and Abuse Issues in the Medical Technology Industry," wherein Michael presented on trends in evidence-based compliance. "We are a small, service-oriented firm that marries substantive expertise with the latest in smart technologies. Our partnership with MDMA could not be a more perfect fit for us," said Bell.

Through this relationship, MDMA members will have special access to R-Squared's proprietary solutions, including Arrangements Keeper(SM), which was designed by leading health lawyers and compliance officers to merge internal controls and data to demonstrate compliant physician/manufacturer relationships, and SpendTracker(SM), which tracks, sorts, trends, and reports on aggregate spend. In addition, MDMA members will be entitled to discounts on consulting services and future software releases, including a to-be-named complete compliance system that is scheduled for release in the fourth quarter.

"Our partnership with R-Squared reflects MDMA's commitment to its members to provide state-of-the-art solutions that will not only help our companies navigate the compliance complexities and avoid costly mishaps, but also provides them with key data and analytics for continuous business improvement," said Mark B. Leahey, Esq., Executive Director of MDMA. "Michael Bell is a foremost expert in medical device compliance matters and a trusted advisor to MDMA and its members. We are pleased to be partnering with Michael and R-Squared."

About R-Squared Services And Solutions, LLC. R-Squared -- short for "reimbursement and regulatory" -- is an independent software and consulting services firm that specializes in compliance and reimbursement strategies and solutions for health care and life sciences industries. To learn more about R- Squared please visit http://www.r2ss.com or call 609.378.5335.

About The Medical Device Manufacturers Association. MDMA is a national trade association based in Washington, D.C., representing innovators and entrepreneurs in the medical device industry. MDMA seeks to improve the quality of patient care by encouraging the development of new medical technology and fostering the availability of innovative products in the marketplace. Please visit http://www.medicaldevices.org to learn more about MDMA.

Contact:

Michael Bell

R-Squared

609-378-5335

mbell@r2ss.com


'/>"/>
SOURCE R-Squared
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. IOF announces 3 orthopaedic sessions at 2008 congress
2. Verus Pharmaceuticals Announces Divestiture of Pediatric GI Development Program to Meritage Pharma
3. NightHawk Radiology Holdings, Inc. Announces Preliminary Results of Its Tender Offer; NightHawk Expects to Purchase 2,367,438 Shares of Its Common Stock at $8.05 per Share
4. Cardiva Medical, Inc. to Present at the Investment In Innovation (In3) Medical Device Summit on June 18, 2008 in San Francisco, CA; Announces the Completion of Its Latest Phase in Its US Sales Force Expansion
5. Therap Services Announces Release 7.3 for the Developmental Disability Community
6. Harpo Productions and Sony Pictures Television Announce Agreement to Launch DR. OZ
7. DiagnoCure announces second quarter 2008 results
8. CardioDynamics Announces Second Quarter 2008 Conference Call and Webcast
9. WorldHeart Announces Voluntary Delisting from the Toronto Stock Exchange
10. Cancer Clinics of Excellence (CCE) Announces Management and Board of Directors Slate at 1st Annual General Membership Meeting
11. MBSB Announces Symbol Change to WNDM
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... Peter Zipp ... in and around the greater Phoenix metropolitan region, is announcing a charity event ... mission of the Homeless Youth Connection is to promote community awareness of the ...
(Date:12/7/2016)... ... December 07, 2016 , ... DrugDev again demonstrated its dedication ... one of the early adopters completing EU-U.S. Privacy Shield Certification from the U.S. Department ... on both sides of the Atlantic with a mechanism to comply with EU data ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... treat wrinkles and deep lines by smoothing and tightening the skin of the ... out there to address facial aging with very little downtime, Silhouette Instalift is ...
(Date:12/7/2016)... , ... December 07, 2016 , ... It is vital ... is with useful, properly analyzed data. The team at Beckman Coulter has designed Kaluza, ... 'need for speed' and the need to operate in a GLP (Good Laboratory Practice) ...
(Date:12/7/2016)... ... December 07, 2016 , ... When it came time to blow out his candles on his ... the Pediatric Heart Transplant team at Joe DiMaggio Children’s Hospital surprised his family ... hospital’s 30th heart transplant recipient. , “He was playing at home, when we got ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... Dec. 7, 2016 A new investigational drug originally ... clinical trials in search of the world,s first treatment to ... of research findings today in the journal Science ... be a watershed moment for millions of people living with ... of Van Andel Research Institute,s Center for ...
(Date:12/7/2016)... 2016 DelveInsight,s, "Janus Kinase 3 ... depth insights on the pipeline drugs and ... 3 (JAK3) Inhibitors. The DelveInsight,s Report covers ... development including Discovery, Pre-clinical, IND, Phase I, ... covers the product clinical trials information and ...
(Date:12/7/2016)... Dec. 7, 2016 Hoovers Research ... performed using the combinational analytical tools. The report ... varied research sources to present unique and reliable ... on the market during the next five years, ... which comprises of sub markets, regional and country ...
Breaking Medicine Technology: